phloretic acid has been researched along with Respiratory Insufficiency in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adler, E; Boissiere, J; Chaubard, JL; De La Cruz, M; Dylla, NP; Giurcanu, M; Hall, JB; Khalid, M; Kress, JP; Lecompte-Osorio, P; Lehmann, C; Leiter, W; Lin, H; Little, J; Moran, D; Mullowney, MW; Nayak, R; Odenwald, M; Pamer, EG; Patel, BK; Pearson, SD; Pohlman, AS; Rose, A; Sidebottom, A; Stutz, MR; Sundararajan, A; Wolfe, KS | 1 |
1 other study(ies) available for phloretic acid and Respiratory Insufficiency
| Article | Year |
|---|---|
Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure.
Topics: Bile Acids and Salts; COVID-19; Humans; Immunity; Pneumonia; Respiratory Insufficiency; SARS-CoV-2 | 2022 |